advertisement

Bharat Biotech seeks nod for intranasal Covid-19 vaccine as booster Dose

India Today Television
New Delhi,UPDATED: Dec 20, 2021 20:19 IST

Bharat Biotech seeks approval for Phase 3 clinical trials of its intranasal vaccine, a first of its kind in India. It has recommended nasal vaccine for booster dose. Bharat Biotech is the second company to submit an application for Phase 3 trial for the third dose in India.

Read more!
More videos from India

VIDEOS FROM OTHER SECTIONS

ProgrammeIndia First

LATEST VIDEOS

advertisement
advertisement